Literature DB >> 27802159

Phosphorylation of STAT2 on serine-734 negatively regulates the IFN-α-induced antiviral response.

Håkan C Steen1, Kevin P Kotredes1, Shoko Nogusa2, Michele Y Harris3, Siddharth Balachandran2, Ana M Gamero4.   

Abstract

Serine phosphorylation of STAT proteins is an important post-translational modification event that, in addition to tyrosine phosphorylation, is required for strong transcriptional activity. However, we recently showed that phosphorylation of STAT2 on S287 induced by type I interferons (IFN-α and IFN-β), evoked the opposite effect. S287-STAT2 phosphorylation inhibited the biological effects of IFN-α. We now report the identification and characterization of S734 on the C-terminal transactivation domain of STAT2 as a new phosphorylation site that can be induced by type I IFNs. IFN-α-induced S734-STAT2 phosphorylation displayed different kinetics to that of tyrosine phosphorylation. S734-STAT2 phosphorylation was dependent on STAT2 tyrosine phosphorylation and JAK1 kinase activity. Mutation of S734-STAT2 to alanine (S734A) enhanced IFN-α-driven antiviral responses compared to those driven by wild-type STAT2. Furthermore, DNA microarray analysis demonstrated that a small subset of type I IFN stimulated genes (ISGs) was induced more by IFNα in cells expressing S734A-STAT2 when compared to wild-type STAT2. Taken together, these studies identify phosphorylation of S734-STAT2 as a new regulatory mechanism that negatively controls the type I IFN-antiviral response by limiting the expression of a select subset of antiviral ISGs.
© 2016. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  Interferon; JAK1; STAT2; Serine phosphorylation; Vesicular stomatitis; Virus infection

Mesh:

Substances:

Year:  2016        PMID: 27802159      PMCID: PMC6518330          DOI: 10.1242/jcs.185421

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  35 in total

1.  Recruitment of Stat4 to the human interferon-alpha/beta receptor requires activated Stat2.

Authors:  J D Farrar; J D Smith; T L Murphy; K M Murphy
Journal:  J Biol Chem       Date:  2000-01-28       Impact factor: 5.157

2.  A hybrid IRF9-STAT2 protein recapitulates interferon-stimulated gene expression and antiviral response.

Authors:  Thomas A Kraus; Joe F Lau; Jean-Patrick Parisien; Curt M Horvath
Journal:  J Biol Chem       Date:  2003-02-05       Impact factor: 5.157

3.  IFN-Stimulated transcription through a TBP-free acetyltransferase complex escapes viral shutoff.

Authors:  Matthew Paulson; Carolyn Press; Eric Smith; Naoko Tanese; David E Levy
Journal:  Nat Cell Biol       Date:  2002-02       Impact factor: 28.824

4.  Genetically engineered vesicular stomatitis virus in gene therapy: application for treatment of malignant disease.

Authors:  Marilyn Fernandez; Mercedes Porosnicu; Dubravka Markovic; Glen N Barber
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

5.  Arginine/lysine-rich structural element is involved in interferon-induced nuclear import of STATs.

Authors:  K Melen; L Kinnunen; I Julkunen
Journal:  J Biol Chem       Date:  2001-01-09       Impact factor: 5.157

6.  Preferential induction of apoptosis by interferon (IFN)-beta compared with IFN-alpha2: correlation with TRAIL/Apo2L induction in melanoma cell lines.

Authors:  M Chawla-Sarkar; D W Leaman; E C Borden
Journal:  Clin Cancer Res       Date:  2001-06       Impact factor: 12.531

Review 7.  Functional classification of interferon-stimulated genes identified using microarrays.

Authors:  M J de Veer; M Holko; M Frevel; E Walker; S Der; J M Paranjape; R H Silverman; B R Williams
Journal:  J Leukoc Biol       Date:  2001-06       Impact factor: 4.962

Review 8.  Serine phosphorylation of STATs.

Authors:  T Decker; P Kovarik
Journal:  Oncogene       Date:  2000-05-15       Impact factor: 9.867

9.  Stat protein transactivation domains recruit p300/CBP through widely divergent sequences.

Authors:  M Paulson; S Pisharody; L Pan; S Guadagno; A L Mui; D E Levy
Journal:  J Biol Chem       Date:  1999-09-03       Impact factor: 5.157

10.  Murine Stat2 is uncharacteristically divergent.

Authors:  C Park; M J Lecomte; C Schindler
Journal:  Nucleic Acids Res       Date:  1999-11-01       Impact factor: 16.971

View more
  9 in total

Review 1.  Interferon signaling in cancer. Non-canonical pathways and control of intracellular immune checkpoints.

Authors:  Diana Saleiro; Leonidas C Platanias
Journal:  Semin Immunol       Date:  2019-06       Impact factor: 11.130

Review 2.  Exposing the Two Contrasting Faces of STAT2 in Inflammation.

Authors:  Philip Duodu; Geohaira Sosa; Jorge Canar; Olivia Chhugani; Ana M Gamero
Journal:  J Interferon Cytokine Res       Date:  2022-07-25       Impact factor: 3.657

Review 3.  Human Disease Phenotypes Associated with Loss and Gain of Function Mutations in STAT2: Viral Susceptibility and Type I Interferonopathy.

Authors:  Christopher James Arthur Duncan; Sophie Hambleton
Journal:  J Clin Immunol       Date:  2021-08-26       Impact factor: 8.317

4.  Deactivation of the antiviral state by rabies virus through targeting and accumulation of persistently phosphorylated STAT1.

Authors:  Gayathri Manokaran; Michelle D Audsley; Haruka Funakoda; Cassandra T David; Katherine A Garnham; Stephen M Rawlinson; Celine Deffrasnes; Naoto Ito; Gregory W Moseley
Journal:  PLoS Pathog       Date:  2022-05-16       Impact factor: 7.464

Review 5.  Interplay between Janus Kinase/Signal Transducer and Activator of Transcription Signaling Activated by Type I Interferons and Viral Antagonism.

Authors:  Yuchen Nan; Chunyan Wu; Yan-Jin Zhang
Journal:  Front Immunol       Date:  2017-12-11       Impact factor: 7.561

6.  Identification of a three miRNA signature as a novel potential prognostic biomarker in patients with bladder cancer.

Authors:  Fei Peng; Hui Li; Hailang Xiao; Ling Li; Yan Li; Yi Wu
Journal:  Oncotarget       Date:  2017-11-06

Review 7.  Fine-Tuning of Type I Interferon Response by STAT3.

Authors:  Ming-Hsun Tsai; Li-Mei Pai; Chien-Kuo Lee
Journal:  Front Immunol       Date:  2019-06-26       Impact factor: 7.561

8.  CDK8 Fine-Tunes IL-6 Transcriptional Activities by Limiting STAT3 Resident Time at the Gene Loci.

Authors:  Jonathan Martinez-Fabregas; Luopin Wang; Elizabeth Pohler; Adeline Cozzani; Stephan Wilmes; Majid Kazemian; Suman Mitra; Ignacio Moraga
Journal:  Cell Rep       Date:  2020-12-22       Impact factor: 9.423

Review 9.  Stat2 stability regulation: an intersection between immunity and carcinogenesis.

Authors:  Cheol-Jung Lee; Hyun-Jung An; Eun Suh Cho; Han Chang Kang; Joo Young Lee; Hye Suk Lee; Yong-Yeon Cho
Journal:  Exp Mol Med       Date:  2020-09-25       Impact factor: 8.718

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.